Eosinophilopoiesis in a murine model of allergic airway eosinophilia: Involvement of bone marrow IL-5 and IL-5 receptor α

Journal of Immunology

Volumn 165, Issue 7, 2000, Pages 4040-4050

  Tomaki, M ^a   Zhao, L L ^a   Lundahl, J ^a   Sjostrand M ^a   Jordana, M ^a   Linden A ^a   O'Byrne, P ^a   Lotvall J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD3 ANTIGEN; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; INTERLEUKIN 5 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CELL KINETICS; CONTROLLED STUDY; EOSINOPHILIA; IMMUNOCYTOCHEMISTRY; INFLAMMATION; LEUKOPOIESIS; LUNG LAVAGE; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY TRACT ALLERGY;

EID: 0034292332     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.7.4040     Document Type: Article

References (57)

1. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions
2. Cellular events in the bronchi in mild asthma and after bronchial provocation
3. Blood and bronchoalveolar eosinophils in allergic subjects after segmental antigen challenge: Surface phenotype, density heterogeneity, and prostanoid production
4. Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation
5. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma: Relationship to bronchial hyperreactivity
6. Eosinophilic inflammation in asthma
7. The eosinophil and bronchial asthma: Current understanding
8. Measurement of airway hyperresponsiveness: New considerations
9. Pulmonary immune cells in health and disease: The eosinophil leucocyte (Part I)
10. Eosinophils
11. 4 by human eosinophils
12. 4 by human eosinophils
13. Activation of bone marrow eosinophils in asthma
14. + hemopoietic progenitor cells in atopic subjects
15. + cells from asthmatic subjects: A novel marker of progenitor cell commitment towards eosinophilic differentiation
16. Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters
17. Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: Regulation by a serum hemopoietic factor
18. Allergen challenge increases cell traffic between bone marrow and lung
19. Mechanisms of allergic pulmonary eosinophilia in the mouse
20. Rapid increase in bone marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge
21. Dose-dependent increase in bone marrow eosinophil content after repeated airway allergen exposure in sensitized mice
22. The inflammatory response in asthma exacerbation: Changes in circulating eosinophils, basophils and their progenitors
23. Allergen-induced asthmatic responses: Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors
24. Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects
25. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model
26. Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia
27. Interleukin-5 modulates eosinophil accumulation in allergic guinea pig lung
28. Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs
29. Effects of an antibody to interleukin-5 in a monkey model of asthma
30. Involvement of IL-5 in a murine model of allergic pulmoaary inflammation: Prophylactic and therapeutic effect of an anti-IL-5 antibody
31. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins
32. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization
33. A non-radioisotopic method for tracing neutrophils in vivo using 5′-bromo-2′-deoxyuridine
34. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies
35. A new membrane permeabilization method for the detection of intracellular antigens by flow cytometry
36. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics
37. Polymorphonuclear leukocyte transit times in bone marrow during streptococcal pneumonia
38. Polymorphonuclear leukocyte (PMN) migration in streptococcal pneumonia: Comparison of older PMN with those recently released from the marrow
39. The distribution and fate of bromodeoxyuridine and bromodeoxycytidine in the mouse and rat
40. + cells in the bronchial mucosa in asthma: Potential airway eosinophil progenitors
41. Evidence for local eosinophil differentiation within allergic nasal mucosa: Inhibition with soluble IL-5 receptor
42. Interleukin-5 expression in the bone marrow of sensitized BALB/c mice after allergen challenge
43. Expression of mRNA for interleukin-5 mucosal bronchial biopsies from asthma
44. Interleukin-4, -5, and -6 and tumor necrosis factor-α in normal and asthmatic airways: Evidence for the human mast cell as a source of these cytokines
45. Detection of cytokines and their cell sources in bronchial biopsy specimens from asthmatic patients: Relationship to atopic status, symptoms, and level of airway hyperresponsiveness
46. + T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics
47. Therapeutic efficacy of an anti-IL-5 monoclonal antibody delivered into the respiratory tract in a murine model of asthma
48. Effects of chronic antiinterleukin-5 monoclonal antibody treatment in a murine model of pulmonary inflammation
49. Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia line HL-60
50. Analysis of interleukin 5 receptors on murine eosinophils: A comparison with receptors on B13 cells
51. Membrane-bound and soluble αIL-5 receptor mRNA in the bronchial mucosa of atopic and nonatopic asthmatics
52. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways
53. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma
54. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo
55. Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: The role of specific adhesion molecules and phosphatidylinositol 3-kinase
56. Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow
57. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: Analysis in a guinea pig model in vivo